Screening and Intervention of Postextubation Dysphagia

Sponsor
National Taiwan University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03284892
Collaborator
Ministry of Science and Technology, Taiwan (Other)
145
1
2
34.6
4.2

Study Details

Study Description

Brief Summary

This study is to develop and test the accuracy of a two-step post-extubation dysphagia screening and the effects of PED Care intervention on reducing time to resume oral intake, rates of penetration and intervention at 10 days postextubation, and incidences of 30-day aspiration pneumonia in adult patients with prolonged intubation (≥48 hours) under a randomized controlled trial (RCT) design.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: PED care
  • Diagnostic Test: FEES test
  • Other: usual care
N/A

Detailed Description

Endotracheal intubation is life-sustaining, but it may contribute to postextubation dysphagia (PED) increasing the risk of penetration, aspiration, and aspiration pneumonia. Up to 84% of extubated patients had PED and approximately 60% penetrated and aspirated that can lead to aspiration pneumonia. The aims of this three-year, two-stage study are: 1) to develop a two-step PED Screen involved oral stereognosis and cough reflex test for detecting penetration and aspiration, using a diagnostic accuracy study method; and 2) to test effects of a once daily, 7-day PED Care intervention on reducing time to resume oral intake, rates of penetration and intervention at 10 days postextubation, and incidences of 30-day aspiration pneumonia in adult patients with prolonged intubation (≥48 hours) from a medical center in Taiwan, using a randomized controlled trial (RCT) design.

Study Design

Study Type:
Interventional
Actual Enrollment :
145 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
The first stage is to test the accuracy of a two-step Post-extubation dysphagia screening tool. Every participants will receive the screening and FEES examination. The second stage of this study will be an intervention study. All participants will randomly assigned into the intervention or control group. The control group only receive the usual care in the unit they stay while the intervention group received additional 7-day, once-daily PED Care including oral exercise, oral cleaning and intake education.The first stage is to test the accuracy of a two-step Post-extubation dysphagia screening tool. Every participants will receive the screening and FEES examination. The second stage of this study will be an intervention study. All participants will randomly assigned into the intervention or control group. The control group only receive the usual care in the unit they stay while the intervention group received additional 7-day, once-daily PED Care including oral exercise, oral cleaning and intake education.
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Screen and Intervene : A Diagnostic Accuracy Study and A Randomized Controlled Trial for Postextubation Dysphagia
Actual Study Start Date :
Sep 19, 2017
Actual Primary Completion Date :
Aug 8, 2020
Actual Study Completion Date :
Aug 8, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: PED Care group

Received PED care addition to usual care

Behavioral: PED care
A once daily, 7-day PED Care intervention on reducing time to resume oral intake, rates of penetration and intervention at 10 days postextubation, and incidences of 30-day aspiration pneumonia in adult patients with prolonged intubation (≥48 hours)

Diagnostic Test: FEES test
Using FEES to see if participants have any aspiration or penetration and the level of it.

Other: usual care
usual care means the original care given by the ward the participants stay.

Active Comparator: Control group

Received usual care only

Diagnostic Test: FEES test
Using FEES to see if participants have any aspiration or penetration and the level of it.

Other: usual care
usual care means the original care given by the ward the participants stay.

Outcome Measures

Primary Outcome Measures

  1. Change from baseline oral intake level in one month post-extubation [Daily, until the 30th days post-extubation]

    Measured by Functional Oral Intake Scale

  2. Change from baseline penetration and aspiration status in 10 days postextubation [First, for baseline assessment, it will be conducted within 48 hrs post-extubation after post-extubation dysphagia screening. Secondly, it will be conducted at 10-day post-extubation for every participants.]

    Measured by Fiberoptic endoscopic evaluation of swallowing (FEES), a dysphagia diagnostic tool

  3. Change from baseline incidence of aspiration pneumonia in one month post-extubation. [Daily, following one month after extubation]

    Will be assessed by Chest X-ray and interpretate by Pulmonologist

Secondary Outcome Measures

  1. Change from baseline Nasogastric tube insertion rate in one month post-extubation. [Daily, following one month after extubation]

    To record the rate of participants who are still using nasogastric tube

  2. Change from baseline unstimulated salivary rate in 10th day post-extubation. [Twice, once within 48 hours post-extubation. Secondly, record it on the 10th day post-extubation.]

    Assess by whatman 41 test strip.

  3. Change from baseline oral health status in 10th day post-extubation. [Twice, once within 48 hours post-extubation. Secondly, record it on the 10th day post-extubation.]

    Assess by whatman 41 test strips.

  4. Change from baseline lip closure and lingual diadochokinetic ability in 10th day post-extubation. [Twice, once within 48 hours post-extubation. Secondly, record it on the 10th day post-extubation.]

    Assess by Frenchay Dysarthria Assessment

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient who is over 20 years old.

  • Patient how has received over 48 hours endotracheal intubation and had been successfully extubated.

Exclusion Criteria:
  • Patient who has neurological deficits or disorders, eg. cerebrovascular disease, Parkinson disease, spinal injury.

  • Patient who has innate / acquired oropharyngeal abnormality

  • Patient who received tracheostomy after extubation.

  • Patient who has already had swallowing dysfunction before endotracheal intubation

  • Patient who cannot follow the instruction and interact with people.

  • Patient who needs absolute quarantine, eg. Open Tuberculosis patients, Severe Acute Respiratory Syndrome (SARS) patients

Contacts and Locations

Locations

Site City State Country Postal Code
1 National Taiwan University Hospital Taipei Taiwan 10055

Sponsors and Collaborators

  • National Taiwan University Hospital
  • Ministry of Science and Technology, Taiwan

Investigators

  • Principal Investigator: Cheryl Chia-Hui Chen, Prof., School of Nursing, College of Medicine, National Taiwan University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT03284892
Other Study ID Numbers:
  • 201705051RIND
First Posted:
Sep 15, 2017
Last Update Posted:
Nov 19, 2021
Last Verified:
Aug 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by National Taiwan University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 19, 2021